All Practice-based pharmacist articles
-
NICE guidelineNICE rheumatoid arthritis guideline
This updated summary of the NICE rheumatoid arthritis guideline includes recommendations on referral, diagnosis, and investigations
-
Independent professional body guideline
BASHH vulvovaginal candidiasis guideline
Recommendations on the diagnostic tests, treatment regimens, and health promotion principles for the effective management of vulvovaginal candidiasis
-
Independent professional body guideline
AWMSG asthma guideline
Core principles of asthma management, inhaler selection and use, and referral guidance, from the All Wales Medicines Strategy Group
-
NICE guideline
NICE antimicrobial prescribing guideline for insect bites and stings
This Guidelines summary covers an antimicrobial prescribing strategy for insect and spider bites and stings in adults, young people, and children
-
NICE guideline
NICE neuropathic pain guideline
This summary of the NICE guidance covers the key principles of care, treatment of neuropathic pain, and treatment of trigeminal neuralgia.
-
PHE/DH/DWP guideline
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19.
-
PHE/DH/DWP guideline
PHE influenza immunisation 2020/21 guideline
This Guidelines summary covers key information on expansion of the 2020-21 flu immunisation programme.
-
NICE guideline
NICE CKS analgesia—mild-to-moderate pain
An overview of the analgesics available to treat mild-to-moderate pain in different patient cohorts.
-
SIGN guideline
SIGN osteoporosis guideline
A brief summary of SIGN's guideline on management of osteoporosis and prevention of fragility fractures, including risk factors and a treatment algorithm.
-
Independent professional body guideline
BTS/SIGN asthma in pregnancy guideline
This summary focuses on recommendations for the management of asthma in pregnant women, including during labour, and recommendations for breastfeeding mothers
-
PHE/DH/DWP guideline
PHE guideline on management of exposure to COVID-19
This summary provides guidance on the management of staff and patients in health and social care settings according to exposures, symptoms, and test results.
-
NHS guideline
PHE maintaining immunisation programmes during COVID-19 guideline
A brief summary providing the key points for primary care on maintaining immunisation programmes during the COVID-19 pandemic.
-
Independent professional body guideline
BTS/SIGN management of difficult asthma guideline
This brief summary of BTS/SIGN guidance on the assessment and management of difficult asthma includes information on contributory factors and monitoring.
-
Independent professional body guideline
FSRH UKMEC contraception guideline
A summary of the FSRH UKMEC guidance on the safety of contraceptive methods, which is set out in clear and concise tables.
-
Independent professional body guideline
ROS guideline: vitamin D and bone health in children
A clear summary on the management of vitamin D deficiency in children and young people.
-
Independent professional body guideline
PCDS management of acne guideline
A concise summary of the Primary Care Dermatology Society's guideline on the treatment of acne vulgaris.
-
Independent professional body guideline
PCDS atopic eczema guideline
An overview of the management of atopic eczema. Covers taking a clinical history, step-by-step treatment, and includes an eczema management plan.
-
PHE/DH/DWP guideline
PHE pneumococcal vaccination guideline (Green Book chapter 25)
A succinct summary of Public Health England’s Green Book chapter 25 pneumococcal vaccination programme
-
Independent professional body guideline
Recognition and management of sepsis in general practice
This Guidelines summary combines recommendations from The UK Sepsis Trust to give guidance on the recognition and management of sepsis in adults, children, and young people over 12 years of age
-
NICE guideline
NICE CKS—constipation in adults
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title, it therefore only covers the information relevant to this setting, and is deliberately concise. Areas covered in the summary include: advice for those with the condition, management (short-duration and chronic), secondary causes of the condition, and prescribing information. Please refer to the full NICE guideline for the complete set of recommendations and references.
